Xiaolu Su

发表

Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.

P. Fitzgerald, W. Cheong, G. Stone, 2015, American heart journal.

Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.

W. Cheong, G. Stone, Jiyan Chen, 2015, Journal of the American College of Cardiology.

Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:

G. Stone, A. Lansky, V. Ng, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial.

W. Cheong, G. Stone, J. Popma, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial

W. Cheong, G. Stone, B. Xu, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial).

G. Stone, A. Lansky, V. Ng, 2011, The American journal of cardiology.

Primary large B-cell lymphoma of the central nervous system with positive NMDAR antibody: a case report

MengJiao Sun, Ning Liu, Xiaolu Su, 2022, BMC Neurology.

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De

G. Stone, A. Lansky, D. Kereiakes, 2010, JACC. Cardiovascular interventions.

Everolimus Eluting Coronary Stent System in the Treatment of ubjects With De Novo Native Coronary Artery Lesions ) Randomized Trials

G. Stone, J. Hermiller, K. Sudhir, 2022 .

Evaluation of the effects of everolimus‐eluting and paclitaxel‐eluting stents on target lesions with jailed side branches: 2‐year results from the SPIRIT III randomized trial

G. Stone, A. Lansky, J. Hermiller, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis

W. Cheong, P. Serruys, G. Stone, 2016, The Lancet.

Periprocedural Myocardial Infarction in a Randomized Trial of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents: Frequency and Impact on Mortality According to Historic Versus Universal Definitions

G. Stone, D. Kereiakes, D. Cutlip, 2012, Circulation. Cardiovascular interventions.

The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.

W. J. van der Giessen, G. Guagliumi, W. Wijns, 2005, Journal of the American College of Cardiology.

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

P. Fitzgerald, G. Stone, K. Mahaffey, 2008, JAMA.

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

G. Stone, D. Kereiakes, D. Cutlip, 2010, Journal of the American College of Cardiology.

SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.

G. Stone, A. Lansky, D. Cutlip, 2009, American heart journal.

Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.

J. Cleveland, N. Uriel, V. Thohan, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial.

G. Stone, J. Hermiller, P. Sood, 2009, American heart journal.

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents.

G. Stone, J. Hermiller, R. Applegate, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.

G. Stone, A. Lansky, R. Applegate, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Minimally invasive endoscopic treatment of gastric leiomyosarcoma: A rare case report and review of literature

Xiaolu Su, guixiang kong, X. Huang, 2021, Advances in Bioengineering and Biomedical Science Research.

COMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS

G. Stone, A. Lansky, D. Kereiakes, 2010 .

A Practical Perspective: Application of the Generalized Approach for Adaptive Design

Jin Wang, Xiaolu Su, Yu Shu, 2020, Therapeutic Innovation & Regulatory Science.